Android app Apple app link

Wells Fargo Boosts RAPT Therapeutics (RAPT) PT to $48 on Promising Anti-IgE Drug Data

By Yahoo! Finance   |   1 month ago
Wells Fargo Boosts RAPT Therapeutics (RAPT) PT to $48 on Promising Anti-IgE Drug Data

Wells Fargo raised RAPT Therapeutics Inc.'s price target to $48 and rated it as Overweight due to positive data on its anti-IgE antibody therapy, showing potential for treating food allergies. The company focuses on developing therapies for oncology and inflammatory diseases.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.